Organ-On-Chip (OOC) Market 2021 - By Organ Type (Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip), By Application (Toxicology Research, Drug Discovery, Molecular Biology, Disease Modelling, Food Safety), By End-User (Biopharmaceutical companies, Academics, Food & Beverages), By Products and Services (Devices, Testing Services), By Type Of Material (Polymer, PDMS, Glass, Silicon), And By Region, Opportunities And Strategies – Global Forecast To 2030

Organ-On-Chip Global Market Opportunities And Strategies To 2021 Including: Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip And Human-On-Chip Covering: CN Bio Innovations, Emulate, TissUse, Mimetas, Hurel, Nortis, InSphero, Tara Biosystems, AxoSim Technologies, Organovo, Ascendence And HemoShear

Starting Price : $5000.00 | Pages : 143 | Published : September 2021 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

Organ On Chip Definition

The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models.

The design and development of an OOC is made possible by using the relevant novel techniques from cell biology, microfabrication, microfluidics, material science and nanotechnology. The specific chip design varies based on manufacturing techniques and the organ it simulates, although the basic structure usually remains the same.

Organ On Chip Size

The global OOC market reached a value of nearly $50.8 million in 2020, having increased at a compound annual growth rate (CAGR) of 59.5% since 2015. The market is expected to grow from $50.8 million in 2020 to $177.8 million in 2025 at a rate of 28.5%. The organ-on-chip market is then expected to grow at a CAGR of 14.6% from 2025 and reach $350.8 million in 2030.

Growth in the historic period resulted from increased demand for personalized medicine, the growing need to minimize financial losses due to late-stage drug failure, and substantial funding of public and private sources for OOC start-ups and research groups. Factors that negatively affected growth in the historic period were the high costs associated with OOCs, the limitations of polydimethylsiloxane (PDMS), the most commonly used substrate material for the fabrication of OOCs and lack of skilled resources for the development of the OOC technology.

Going forward, the adoption of OOC technology by major pharmaceutical companies such as Roche and AstraZeneca among many others, increasing drug repurposing approaches in the OOC industry, and rising healthcare expenditure will drive growth in the forecast period. Factors that could hinder the growth of the OOC market in the future include compatibility problems that may occur due to the lack of standardization, OOCs are not high throughput to conduct multiple assays, cell survivability issues, the COVID-19 pandemic, and resistance in the adoption and regulation of new medical options can negatively impact the market growth.

Organ On Chip Drivers

The key drivers of the organ on chip market include:

Increasing Demand For Personalized Medicine

Personalized medicine is an evolving field that allows physicians to develop a targeted treatment for their patients, i.e., to choose the best possible drug at the right dose based on the needs of an individual patient. It holds a great promise for improving patient’s health outcomes, especially in the areas where a detailed understanding of each person’s phenotype and disease profile is important. Personalized medicine has a strong impact on the healthcare industry leading to the increasing for personalized medicine worldwide, especially in cancer treatments. Under controlled and dynamic microenvironment conditions, the microfluidic systems with integrated stem cells exhibit functions that emulate individual organ-level physiology. These personalized models help predict patient-specific toxicity and efficacy. In the future, by focusing on early disease detection with the support of personalized medicine, patients will be matched with the most suitable treatments that will work for them. For instance, in 2021, InSphero AG and ETH Bio Engineering Laboratory had announced a licensing agreement for InSphero's Akura Flow organ-on-a-chip platform. Also, Researchers at the US Army Combat Capabilities Development Command (CCDC) and Chemical Biological Center (CBC) used Emulat's lung on chip technology for research on COVID-19.

Organ On Chip Restraints

The key restraints on the organ on chip market include:

High-Costs Associated With OOCs

OOCs are considered to be more relevant and accurate than animal models or cell cultures in drug discovery and development. However, the cost of these chips and redesigning steps to suit mass production are high.  High production costs are restraining the OOC market growth as expensive redesigning process might be a burden for the relatively small companies involved. Furthermore, the conceptual designing of bioreactors, pumps for perfusion of cell culture medium, maintenance of cell environment, mechanical stimuli, and implementing cell analysis methods are all complex and require additional costs. The cost incurred in the production upscaling might also reflect on the price of the chip making it unaffordable for pharmaceutical companies. Creating an OOC is also not a simple process and the challenges that need to overcome in the process include reproducing the architectural complexity of the human tissues and organs on a device in a miniaturized fashion, and linking and arranging them in the right format for the interconnected systems to recapitulate the human tissue/organ interactions.  Additionally, most companies in the pharmaceuticals industry will have to switch from polydimethylsiloxane (PDMS) prototyping and small-series to large-scale production in other materials (glass, polymer injection moulding) that will increase the expenditure and is likely to slow down the growth of OOC companies.

Organ On Chip Trends

The key trends influencing in organ on chip include:

Big data For Organs-On-Chips

Organs-on-chips manufacturing companies are increasingly adopting big data to deal with the data generated through OOCs. Data generated from OOCs can rise to several challenges, including sharing, integrating and analyzing the data. In order to effectively use the generated data, implementation of big data algorithms on modern high performance computing systems is pivotal. For instance, Netri, a France based company offering organs-on-chip for the industry, have developed algorithms to extract most of functional network markers OOCs (connectivity map between chambers, weight of connections, small worldness of the network) that are compatible with MEA (Micro Electrode Arrays) devices from main suppliers. These MEA are the standard technology used to detect electrophysiological signals. Continuous recordings provide data to investigate a compound’s impact on functional activity and network dynamics.

Developments In The Testing Of Human Organs-On-Chips

Human organs-on-chips (OOCs) are miniaturized versions of lungs, livers, kidneys, heart, brain, intestines and other vital human organs embedded in a chip. With advances in OOC technology, drug regulatory bodies have started testing OOCs for their reliability and their use as an alternative to animal testing.   For instance, in February 2018, Roche teamed up with Emulate, a USA-based biotechnology company, to expand their organ-on-chip testing technology. Roche plans on using Emulates Human Emulation system to better predict the safety and efficacy of its drug candidates. This partnership allows the Swiss pharmaceutical company access to Emulates OOC for discovery and development of new classes of therapeutics antibodies and drug combinations. Also, in April 2017, the US FDA announced an agreement with Emulate Inc., to evaluate the company’s human organ-on-chip technology in laboratories. The OOC technology offers a less time-consuming and cost-effective way to test drugs, foods, cosmetics and dietary supplements for efficacy and toxicity. Emulate Inc. was founded by researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University, and is the first commercial organ-on-chip venture. Companies such as Johnson & Johnson and Merck have also partnered with Emulate to test and develop applications for its human OOC technology.

Opportunities And Recommendations In The Organ On Chip

Opportunities –


The top opportunities in the OOC market segmented by organ type will arise in the Heart-on-chip segment, which will gain $20.1 million of global annual sales by 2025.The top opportunities in the OOC market segmented by application will arise in the Toxicology Research segment, which will gain $39.8 million of global annual sales by 2025. The top opportunities in the OOC market segmented by end-users will arise in the Biopharmaceutical companies’ segment, which will gain $73.0 million of global annual sales by 2025. The top opportunities in the OOC market segmented by products & services will arise in the Testing segment, which will gain $66.3 million of global annual sales by 2025. The top opportunities in the OOC market segmented by type of material will arise in the Polymer segment, which will gain $371.7 kilo units of global annual sales by 2025. The OOC market size will gain the most in the North America at $64.7 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends that OOC companies consider developing human-on-chip models that will reduce the need of animal testing, focus on R&D to develop disease models for liver, lungs, hearts, and other organs, focus on pricing based on economies, use Direct-To-Consumer (DTC) advertising, and collaborate with pharmaceutical companies.

Organ On Chip Segmentation

Organ on chip market is segmented by organ, by application, by end user, by products & services, type of material, and by geography.
By Organ –
The organ on chip market is segmented by organ into
    • a) Lung-On-Chip
    • b) Heart-On-Chip
    • c) Liver-On-Chip
    • d) Intestine-On-Chip
    • e) Kidney-On-Chip
    • f) Skin-On-Chip
    • g) Blood-Brain-Barrier-On-Chip
    • h) Other Organ Models
The other organ model segment was the largest segment of the OOC market segment by organ, accounting for 14.6% of the total in 2020. Going forward, the heart-on-chip segment is expected to be the fastest-growing segment at a CAGR of 32.6% during 2020-2025.
By Application –
The OOC market is segmented by application into
    • a) Toxicology Research
    • b) Drug Discovery
    • c) Molecular Biology
    • d) Disease Modelling
    • e) Food Safety
    • f) Other Applications
The toxicology research segment was the largest segment of the OOC market by application, accounting for 30.4% of the total in 2020. Going forward, the drug discovery segment is expected to be the fastest-growing segment at a CAGR of 30.2% during 2020-2025.
By End User –
The OOC market is segmented by end user into
    • a) Biopharmaceutical companies
    • b) Academics
    • c) Food & Beverages
    • d) Other Commercial Industries
The biopharmaceutical companies’ segment was the largest segment of the OOC market by end-users, accounting for 54.4% of the total in 2020. Going forward, the biopharmaceutical companies is expected to be the fastest-growing segment at a CAGR of 29.5% during 2020-2025.
By Products & Services –
The OOC market is segmented by products & services into
    • a) Devices
    • b) Testing Services
The testing segment was the largest segment of the OOC market by product & services, accounting for 57.6% of the total in 2020. Going forward, the device segment is expected to be the fastest-growing segment at a CAGR of 30.7% during 2020-2025.
By Type of Material –
The OOC market is segmented by type of material into
    • a) Polymer
    • b) PDMS
    • c) Glass
    • d) Silicon

By Geography –
The OOC market is segmented by geography into
      o Asia
      o North America
      o Europe
North America was the largest market for OOC, accounting for 55.7% of the global market in 2020. It was followed by Europe, Asia and then rest of the world. Going forward, Asia and Rest of the world will be the fastest growing regions in the OOC market, where growth will be at CAGRs of 34.1% and 33.0% respectively during 2020-2025. These will be followed by Europe and North America where the markets are expected to grow at CAGRs of 28.5% and 26.9% respectively.

Organ On Chip Competitive Landscape

Major Competitors In The Organ On Chip Market Are:

  • Emulate Inc.
  • Mimetas BV
  • AxoSim Inc.
  • Nortis Inc.
  • TissUse GmbH
  • Other Competitors In The Organ On Chip Market Include:

  • Micronit
  • BEOnChip
  • CN Bio Innovations
  • Mesobiotech
  • InSphero AG
    1. Table Of Contents

    2. 1 Organ-On-Chip Market Executive Summary
    3. 2 Table of Contents
    4. 3 List of Figures
    5. 4 List of Tables
    6. 5 Report Structure
    7. 6 Introduction
      • 6.1. Segmentation By Organ Type
      • 6.2. Market Segmentation By Type Application
      • 6.3. Market Segmentation By End User
      • 6.4. Market Segmentation By Products & Services
      • 6.5. Market Segmentation By Type Of Material
    8. 7 Organ On Chip Market Characteristics
      • 7.1. Market Definition
      • 7.2. Market Segmentation By Organ Type
        • 7.2.1. Lung-On-Chip
        • 7.2.2. Heart-On-Chip
        • 7.2.3. Liver-On-Chip
        • 7.2.4. Intestine-On-Chip
        • 7.2.5. Kidney-On-Chip
        • 7.2.6. Skin-On-Chip
        • 7.2.7. Blood-Brain-Barrier-On-Chip
        • 7.2.8. Other Organ Models
      • 7.3. Market Segmentation By Application
        • 7.3.1. Toxicology Research  23
        • 7.3.2. Drug Discovery  23
        • 7.3.3. Molecular Biology  23
        • 7.3.4. Disease Modelling  23
        • 7.3.5. Food Safety  23
        • 7.3.6. Other Applications  23
      • 7.4. Market Segmentation By End User
        • 7.4.1. Biopharmaceutical companies
        • 7.4.2. Academics
        • 7.4.3. Food & Beverages
        • 7.4.4. Other Commercial Industries
      • 7.5. Market Segmentation By Products & Services
        • 7.5.1. Devices
        • 7.5.2. Testing Services
      • 7.6. Market Segmentation By Type Of Material
        • 7.6.1. Polymer
        • 7.6.2. PDMS
        • 7.6.3. Glass
        • 7.6.4. Silicon
      • 7.7. Organs-On-Chips Origin And Significance
      • 7.8. Organ-On-Chip Features
      • 7.9. OOC Applications
        • 7.9.1. Applications Of OOCs In The Healthcare Industry
        • 7.9.2. Other Applications Of OOCs
    9. 8 OOC Market, Product Analysis –Product Examples
        • 8.1.1. Technical Description
        • 8.1.2. Typical Organ-On-Chip Structure
        • 8.1.3. Product Design Materials
        • 8.1.4. Product Design Methodologies
      • 8.2. OOC Products In The Market
        • 8.2.1. New Product Launches
        • 8.2.2. Products In The Pipeline
    10. 9 OOC Market, Value Chain Analysis
        • 9.1.1. Organ/Tissue Physiology
        • 9.1.2. Microfluidic Chip and Biosensors
        • 9.1.3. 3D Cell Culture
        • 9.1.4. Gas & Liquid Perfusion
      • 9.2. Organ-On-Chip Market – Business Models
        • 9.2.1. Academic Universities/Institutes
        • 9.2.2. Spin-offs
        • 9.2.3. OOC Development Companies
        • 9.2.4. Commercial Industries/End-Users
        • 9.2.5. Research Organizations
        • 9.2.6. OOC Pricing
    11. 10 Overview Of Organ-Specific Models
      • 10.1.1. Lung-On-Chip
      • 10.1.2. Heart-On-Chip
      • 10.1.3. Liver-On-Chip
      • 10.1.4. Intestine-On-Chip
      • 10.1.5. Kidney-On-Chip
      • 10.1.6. Skin-On-Chip
      • 10.1.7. Blood-Brain-Barrier-On-Chip
      • 10.1.8. Human-On-Chip
    12. 11 Traditional Methods Versus Organ On Chip For Drug Discovery
    13. 12 OOC Market Trends And Strategies
      • 12.1.1. Developments In The Testing Of Human Organs-On-Chips
      • 12.1.2. Organ-On-Chip Technology In Space
      • 12.1.3. Automated Monitoring Of Organs-On-Chips
      • 12.1.4. 3D Printing Of Organs-On Chips
      • 12.1.5. Manufacturers Tying Up With End-Users To Design Tailor-Made Products
      • 12.1.6. Investment In Integration Of Individual Organs-On-Chips Into Humans-On-Chips
      • 12.1.7. Strong Focus On Development Of Custom Organs-On-Chips
      • 12.1.8. Manufacturers Work On Disease Models To Expedite Drug Testing
      • 12.1.9. Rise In The Collaborations Between Organs-On-Chips Manufacturers And Pharmaceutical Companies
      • 12.1.10. Increase In Funding To Develop The Organ-On-Chip Platform
    14. 13 Collaborations, Partnerships And Agreements
    15. 14 Recent Developments/Research
      • 14.1. Pancreas-On-A-Chip
      • 14.2. Retina-On-A-Chip
      • 14.3. Bronchi-On-A-Chip
      • 14.4. Tumor-On-A-Chip
      • 14.5. Organ-On-An-Electronic-Chip
      • 14.6. Human Spinal Cords On A Chip
      • 14.7. Biosensors In Organ-On-A-Chip
      • 14.8. Placenta-On-A-Chip
      • 14.9. OOCs For Hepatitis B Virus Testing
      • 14.10. Blood-Vessel-On-A-Chip
      • 14.11. Development Of Chip Technology Through Partnerships And Acquisitions
      • 14.12. Growth In Research Grants
    16. 15 Organ-On-Chip Porter’s Five Forces Analysis
    17. 16 Organ-On-Chip Unmet Needs
      • 16.1. Lack Of Data Supported Evidence
      • 16.2. Ease Of Use And Automation
      • 16.3. Lack Of Personalized Understanding Of Diseases
      • 16.4. Organ Specific Needs
      • 16.5. OOC Patents and Publications
    18. 17 Global OOC Market Size And Growth
      • 17.1. Historic Market Growth, Value ($ Million)
      • 17.2. Forecast Market Growth, Value ($ Million)
    19. 18 Global OOC Market Drivers And Restraints
      • 18.1. Market Drivers
        • 18.1.1. Increasing Demand For Personalized Medicine
        • 18.1.2. Growing Need To Minimize Financial Losses Due To Late Stage Drug Failure
        • 18.1.3. Substantial Funding Of Public And Private Sources For OOC Start-Ups And Research Groups
        • 18.1.4. Adoption Of OOC Technology By Major Pharmaceutical Companies Such As Roche And AstraZeneca Among Many Others
        • 18.1.5. Increasing Drug Repurposing Approaches
        • 18.1.6. Rising Healthcare Expenditure
      • 18.2. Market Restraints
        • 18.2.1. High-Costs Associated With OOCs
        • 18.2.2. Compatibility Problems May Occur Due To The Lack Of Standardization
        • 18.2.3. Limitations Of Polydimethylsiloxane (PDMS), The Most Commonly Used Substrate Material For The Fabrication Of Oocs
        • 18.2.4. Resistance In The Adoption And Regulation Of New Medical Options
        • 18.2.5. Need For Skilled Resources For The Development Of OOC Technology
        • 18.2.6. OOCs Are Not High Throughput To Conduct Multiple Assays
        • 18.2.7. Cell Survivability Issues Can Negatively Impact The Market Growth
    20. 19 OOC Market, Regional Analysis
      • 19.1. Global OOC Market, 2019, By Region, Value ($ Million)
        • 19.1.1. North America
        • 19.1.2. Europe
        • 19.1.3. Rest Of The World
      • 19.2. Global OOC Market, 2015 – 2023, Historic And Forecast, By Region
    21. 20 Global OOC Market Segmentation
      • 20.1. Global OOC Market, Segmentation By Organ, 2019, Value ($ Million)
        • 20.1.1. Multi- Organs On Chip
        • 20.1.2. Liver-On- Chip
        • 20.1.3. Intestine- On-Chip
      • 20.2. Global OOC Market, 2015 - 2023, Historic and Forecast, Segmentation By Organ
        • 20.2.1. Liver-On-Chip
        • 20.2.2. Multi-Organs On Chip
        • 20.2.3. Blood-Brain Barrier (BBB)-On-Chip
      • 20.3. Global OOC Market, Segmentation By Application, 2019, Value ($ Million)
        • 20.3.1. Toxicology Research
        • 20.3.2. Drug Discovery
        • 20.3.3. Other Applications
      • 20.4. Global OOC Market, 2015 - 2023, Historic and Forecast, Segmentation By Application
        • 20.4.1. Drug Discovery segment
        • 20.4.2. Toxicology Research segment
        • 20.4.3. Other Applications segment
      • 20.5. Global OOC Market, Segmentation By End User, 2019, Value ($ Million)
        • 20.5.1. Biopharmaceutical Companies
        • 20.5.2. Academics
        • 20.5.3. Food & Beverages
      • 20.6. Global OOC Market, 2015 - 2023, Historic and Forecast, Segmentation By End User
        • 20.6.1. Academics segment
        • 20.6.2. Biopharmaceutical Companies segment
        • 20.6.3. Other Commercial Industries segment
      • 20.7. Global OOC Market, Segmentation By Products & Services, 2019, Value ($ Million)
        • 20.7.1. Devices
        • 20.7.2. Testing Services
      • 20.8. Global OOC Market, 2015 - 2023, Historic and Forecast, Segmentation By Products & Services
        • 20.8.1. Devices
        • 20.8.2. Testing Services
      • 20.9. Global OOC Market, Segmentation By Type Of Material, 2019, Volume (Kilo Units)
        • 20.9.1. Polymer
        • 20.9.2. PDMS
        • 20.9.3. Silicon
      • 20.10. Global OOC Market, 2015 - 2023, Historic and Forecast, Segmentation By Type Of Material
        • 20.10.1. Polymer
        • 20.10.2. Silicon
        • 20.10.3. PDMS
    22. 21 Global OOC Market Competitive Landscape
      • 21.1. Mergers and Acquisitions
        • 21.1.1. BioIVT Acquired Ascendance Biotechnology
      • 21.2. Company Profiles
      • 21.3. Emulate Inc.
        • 21.3.1. Company Overview
        • 21.3.2. Products And Services
        • 21.3.3. Business Strategy
        • 21.3.4. Financial Overview
      • 21.4. AxoSim Inc.
        • 21.4.1. Company Overview
        • 21.4.2. Products And Services
        • 21.4.3. Business Strategy
        • 21.4.4. Financial Overview
      • 21.5. Kirkstall
        • 21.5.1. Company Overview
        • 21.5.2. Products And Services
        • 21.5.3. Business Strategy
        • 21.5.4. Financial Overview
      • 21.6. TissUse GmbH
        • 21.6.1. Company Overview
        • 21.6.2. Products And Services
        • 21.6.3. Business Strategy
        • 21.6.4. Financial Overview
      • 21.7. Nortis Inc.
        • 21.7.1. Company Overview
        • 21.7.2. Products And Services
        • 21.7.3. Financial Overview
      • 21.8. Mimatas BV
        • 21.8.1. Company Overview
        • 21.8.2. Products And Services
        • 21.8.3. Business Strategy
        • 21.8.4. Financial Overview
    23. 22 Global Organ-On-Chip Market – Funding Landscape
      • 22.1.1. Funding Landscape – North America
      • 22.1.2. Funding Landscape – Europe
      • 22.1.3. Funding Landscape – Asia
      • 22.1.4. Funding Landscape – ROW
    24. 23 Global OOC Market Opportunities And Strategies
      • 23.1. Global OOC Market In 2023 – Regions Offering Most New Opportunities
      • 23.2. Global OOC Market In 2023 – Segments Offering Most New Opportunities
      • 23.3. Global Organ-On-Chip Market In 2023- Growth Strategies
        • 23.3.1. Market Trend Based Strategies
        • 23.3.2. Competitor Strategies
    25. 24 Conclusions And Recommendations
      • 24.1. Conclusions
      • 24.2. Recommendations
        • 24.2.1. Product
        • 24.2.2. Price
        • 24.2.3. Place
        • 24.2.4. Promotion
        • 24.2.5. People
    26. 25 Appendix
      • 25.1. Market Data Sources
      • 25.2. Research Methodology
      • 25.3. Currencies
      • 25.4. Research Inquiries
      • 25.5. The Business Research Company
      • 25.6. Copyright and Disclaimer

    List Of Tables

      Table 1:  Global Organ-On-Chip Market, List Of Universities And Their Spin-offs
    • Table 2: Global Organ-On-Chip Market, New Product Launches
    • Table 3: Global Organ-On-Chip Market, Products In The Pipeline
    • Table 4: Limitations Of Traditional Methods Over Organs-On-Chips
    • Table 5: Global Organ-On-Chip Market, Collaborations, Partnerships And Agreements
    • Table 6: Global Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Table 7: Global Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 8: Global Organ-On-Chip (OOC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 9: Global Organ-On-Chip (OOC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 10: Global Organ-On-Chip (OOC) Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 11: Global Organ-On-Chip (OOC) Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Table 12: Global Organ-On-Chip (OOC) Market, Segmentation By Organ, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 13: Global Organ-On-Chip (OOC) Market, Segmentation By Organ, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 14: Global Organ-On-Chip (OOC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 15: Global Organ-On-Chip (OOC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 16: Global Organ-On-Chip (OOC) Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 17: Global Organ-On-Chip (OOC) Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 18: Global Organ-On-Chip (OOC) Market, Segmentation By Products & Services, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 19: Global Organ-On-Chip (OOC) Market, Segmentation By Products & Services, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 1620: Global Organ-On-Chip (OOC) Market, Segmentation By Type Of Material, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Volume (Kilo Units)
    • Table 21: Global Organ-On-Chip (OOC) Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
    • Table 22: Global Organ-On-Chip (OOC) Market, Per Capita Average Organ-On-Chip (OOC) Market Industry Expenditure, 2015 – 2025, ($)
    • Table 23: Asia Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Table 24: Asia Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 25: Europe Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Table 26: Europe Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 27: North America Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Table 28: North America Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 29: Global OOC Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 30: Global Organ-On-Chip Market, Institutions Funded By NIH, 2019
    • Table 31: Global Organ-On-Chip Market, Institutions Funded By NCATS For Tissue Chip Testing Centers, 2016
    • Table 32: Global Organ-On-Chip Market, Institutions Funded By NCATS, 2017
    • Table 33: Global Organ-On-Chip (OOC) Market Size Gain ($ Million), 2020 – 2025, By Region
    • Table 34: Global Organ-On-Chip (OOC) Market Size Gain ($ Million), Segmentation By Organ, 2020 – 2025
    • Table 35: Global Organ-On-Chip (OOC) Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 36: Global Organ-On-Chip (OOC) Market Size Gain ($ Million), Segmentation By End-User, 2020 – 2025
    • Table 37: Global Organ-On-Chip (OOC) Market Size Gain ($ Million), Segmentation By Products & Services, 2020 – 2025
    • Table 38: OOC - Market Data Sources

    List Of Figures

      Figure 1: Global Organ-On-Chip (OOC) Market Segmentation By Organ
    • Figure 2: Global Organ-On-Chip Market Segmentation By Application
    • Figure 3: Global Organ-On-Chip Market Segmentation By End User
    • Figure 4: Global Organ-On-Chip Market Segmentation By Products & Services
    • Figure 5: Global Organ-On-Chip Market Segmentation By Type Of Material
    • Figure 6: Global Organ-On-Chip Market, Simplified Synopsis of Value Chain Analysis
    • Figure 7: Global Organ-On-Chip Market, OOC Players Positioning Along The Value Chain
    • Figure 8: Global Organ-On-Chip Market, Supply Chain Analysis
    • Figure 9: Global Organ-On-Chip Market, Typical Business Model Of OOC Companies
    • Figure 10: Global Organ-On-Chip Market, Typical Organ-On-Chip Structure
    • Figure 11: Global Organ-On-Chip Market, Lung-On-Chip Model
    • Figure 12: Global Organ-On-Chip Market, Heart-On-Chip Model
    • Figure 13: Global Organ-On-Chip Market, Liver-On-Chip Model
    • Figure 14: Global Organ-On-Chip Market, Intestine-On-Chip Model
    • Figure 15: Global Organ-On-Chip Market, Kidney-On-Chip Model
    • Figure 16: Global Organ-On-Chip Market, Skin-On-Chip Model
    • Figure 17: Global Organ-On-Chip Market, Blood-Brain-Barrier-On-Chip Model
    • Figure 18: Global Organ-On-Chip Market, Human-On-Chip Model
    • Figure 19: Global Organ-On-Chip Market, Multi-Organ-On-Chip Model
    • Figure 20: Global Organ-On-Chip Market, Porter’s Five Forces Analysis
    • Figure 21: Global Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Figure 22: Global Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 23: Global Organ-On-Chip (OOC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 24: Global Organ-On-Chip (OOC) Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Figure 25: Global Organ-On-Chip (OOC) Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Figure 26: Global Organ-On-Chip (OOC) Market, Segmentation By Organ, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Global Organ-On-Chip (OOC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 28: Global Organ-On-Chip (OOC) Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Global Organ-On-Chip (OOC) Market, Segmentation By Products & Services, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Asia Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Figure 31: Asia Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 32: Europe Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Figure 33: Europe Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 34: North America Organ-On-Chip (OOC) Market, Historic, 2015 – 2020, $ Million
    • Figure 35: North America Organ-On-Chip (OOC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: Global  OOC Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 37: Global Organ-On-Chip Market Funding Landscape Split By Regions, 2015-2017, Value, ($ million)
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report

    Frequently Asked Questions

    What is the definition of the organ-on-chip market?

    The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models. request a sample here

    How will the organ-on-chip market drivers and restraints affect organ-on-chip market dynamics? What forces will shape the organ-on-chip industry going forward?

    The organ-on-chip market growth is aided by adoption of ooc technology by major pharmaceutical companies. However, some organ-on-chip market restraints include high-costs associated with OOCs request a sample here

    What is the forecast market size of the organ-on-chip market?

    The global organ-on-chip market was valued at $41.6 billion in 2019 having grown at a CAGR (compound annual growth rate) of almost 70.5% request a sample here

    How is the organ-on-chip market segmented?

    The global organ-on-chip market is segmented -
    1) By Organ Type- Lung-On-Chip, Multi-Organs On Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip, Other Organ Models
    2) By Application – Toxicology Research, Drug Discovery, Molecular Biology, Disease Modelling, Food Safety, Other Applications
    3) By End Uses – Biopharmaceutical companies, Academics, Food & Beverages, Other commercial industries
    4) By By Products And Services– Devices, Testing Services
    5) By Type Of Material- Polymer, PDMS, Glass, Silicon
    request a sample here

    Which region has largest share, and what is the market size and growth by geography according to the organ-on-chip global market report?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    Who are the key players of the global organ-on-chip market?

    Top competitors in the organ-on-chip market include Emulate Inc., AxoSim Inc., Kirkstall, TissUse GmbH, Nortis Inc., Mimetas BV request a sample here.

    What are the key trends in the global organ-on-chip market?

    Major trends influencing the organ-on-chip market include developments in the testing of human organs-on-chips request a sample here.

    What are the major opportunities in the organ-on-chip market and the approaches companies can take to take advantage of them?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    How does the organ-on-chip market relate to the overall economy and other similar markets?